Personalized DNA vaccine for recurrent childhood brain tumors
Part of Brain & nervous system, Cancer clinical trials.
This trial tests a personalized DNA vaccine made from your tumor’s DNA (neoantigens) to help your immune system fight the cancer. It is designed for children and young adults with certain recurrent or newly diagnosed brain/spine tumors, after they have had other standard treatments and tumor tissue is available for testing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Aged 12–25 and have a qualifying brain or spine tumor (high-grade glioma or diffuse midline glioma newly diagnosed, or other pediatric CNS tumors with recurrent or resistant disease).
- You must have tumor tissue available for sequencing to find target “neoantigens” (tumor markers that can be recognized by the immune system).
- Your doctor expects you may live more than 24 weeks for the tissue-testing step and more than 12 weeks for the treatment step.
- You must be able to consent (or have a guardian who can), and agree to use effective birth control during the study.
- You can’t have certain serious vaccine reactions, uncontrolled medical problems, or active immune-suppressing conditions that would block an immune response.
- If the vaccine cannot be made (no usable neoantigen found), you cannot continue into treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a personalized vaccine created by AI to target your specific brain tumor. It is for people with a glioma that came back after standard treatments like surgery, radiation, or chemotherapy, and whose tumor has enough genetic mutations to make the vaccine.
This trial tests a personalized vaccine made from your own immune cells (dendritic cells) to treat glioblastoma that has come back after standard treatment. The vaccine is designed to help your immune system recognize and attack your tumor.
This trial tests a new immune therapy using your child's own specially trained white blood cells to fight brain tumors. The treatment is given directly into the fluid around the brain, and it is for children with specific types of brain cancer.
This trial tests a personalized mRNA vaccine designed to teach your immune system to attack your specific tumor. It is for people with advanced gastrointestinal cancers who have exhausted other options.
This early-phase trial tests a personalized immune treatment made from your tumor’s specific “neoantigen” targets (small pieces the immune system can recognize), plus an immune-boosting medicine. It aims to help control certain cancers by training your immune system to attack your tumor.
This trial tests a vaccine that may help the immune system fight brain tumors (medulloblastoma, high-grade glioma, and DIPG). It is for patients who have already had standard treatment and whose tumors are still present or have returned.
Hear when a new Pediatric Recurrent Central Nervous System Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.